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Introduction  to-human transmission also reported in some cases in 
various countries [2]. Infectious diseases are the leading contributors of 
mortality and morbidity in humans and animals across  History
the globe. Many emerging diseases, even epidemics  CCHF was first described in the Crimea, Russia  are a direct consequence of zoonosis. Some infectious  in 1944 by soviet scientists during an outbreak which  diseases like viral hemorrhagic fevers (VHFs)are a  involved  200  cases  of  CCHF  in  soviet  military  matter of great concern due to their zoonotic nature and  personnel. They called it Crimean hemorrhagic fever  associated fatality. VHFs are now becoming a severe  (CHF) [3]. Later in 1956 it was found that the causative  threat  to  animals  and  humans.  Crimean-Congo  agent was identical to a virus isolated from a patient in  hemorrhagic fever (CCHF) is one of the most widely  Congo and the name CCHF was adopted after that [5].  distributed viral hemorrhagic fevers among these [1]. It 
Epidemiology and geographical distribution is  an  emerging  zoonotic  disease  which  has  drawn 
attention of international community . Although, it is  CCHFV  has  a  mostextensive  geographic 
new  to  India,  outbreaks  have  been  recorded  from  distribution among all tick viruses and it is widespread 
various countries in Africa, Asia, South-East Europe,  in  Eurasia  and  Africa  [6,7].  The  geographic 
and Middle East [2]. distribution  pattern  of  disease  coincides  with  the 
CCHF is a tick born viral zoonotic disease caused  distribution  of  Hyalomma  tick  vector.  The  virus  is 
by virus of genus Nairovirus of Bunyaviridae family  reported  from about 30 countries which include Africa 
[3]. The disease is distributed globally which can be  (Uganda,  Sudan,    Democratic  Republic  of  Congo, 
correlated by the global distribution of the tick vector  Nigeria, Mauritania, Senegal and South Africa etc), 
(Hyalomma  tick)  which  is  responsible  for  viral  Southeast Europe (Kosovo, Russia, Bulgaria, Greece 
transmission  [2]. The disease has been recognized by  and Turkey etc.), Middle East (Iraq, Iran, Saudi Arabia 
different  names  as  Asian  Ebola,  Hungribta  (blood  and  Oman)  and  Asia  (Kazakhstan,  Tajikistan, 
taking), Khunymuny (nose bleeding) or Karakhalak  Uzbekistan, Pakistan, China and India) [8, 9, 10].
(Black Death) in the different parts of world [4]. In the  In Africa, due to limited sanitary facilities, virus 
last  2  years,  in  India,  CCHF  is  emerging  as  an  surveillance is difficult. In the last decade lesser than 
important zoonotic disease and a potential threat for the  100 cases were reported in Africa and most of the cases 
persons associated with animals as farmers, animal  occurred  in  South  Africa  [11].  In  2003,  outbreak 
handlers  and  veterinarians  due  to  its  potential  occurred in Mauritania [12] and in 2008, a nosocomial 
transmission from animal to human. However, human- outbreak was reported in Sudan [11, 13].
In Europe, Bulgaria is the only country where 
CCHF is endemic but outbreaks have been recorded 
with increased number of cases in other countries like 
Kosovo, Turkey, Albania, Ukraine and South-west of 
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Abstract
Crimean-Congo Hemorrhagic Fever (CCHF) is an emerging tick-born zoonotic disease in India which is caused by Nairovirus 
of Bunyaviridae family. CCHF is reported from about 30 countries of the world. An outbreak of CCHF has been reported two 
years back in Gujarat which killed four people including two physicians, one nurse and a rural housewife. Tick bite, contact 
with infected material and nosocomial routes are the main routes of infection. This disease is not much important in animals as 
animals are asymptomatic but domestic livestock play a vital role in the transmission of disease to humans. So the persons 
associated with animals like veterinarians, farmers and slaughter house workers are also at the high risk of getting the 
infection. The disease has a great public health importance. Rapid diagnosis of disease is very important. The advent of 
molecular techniques including real-time PCR allow the rapid diagnosis of CCHF. There are limited treatment options for 
CCHF. Ribavirin is the only known drug which is effective against CCHF. 
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the Russian Federation [14].  Between 1997 and 2009,  contaminated blood or tissues from infected patient. 
a total of 159 CCHF cases were identified in Bulgaria  This may occur primarily in hospital setting causing 
[15]. In Turkey also, an increased number of CCHF  nosocomial  infection  [20].  Aerosol  or  airborne 
cases were reported between year 2002 and 2009[16].  infection is also reported in Russia [32]. There may be 
CCHF is also widespread in Asia and middle-east [2,  horizontal transmission from a mother to her child 
8]. Some of the recent outbreaks are listed in Table-1.  which indicates the need of preventive measures for in-
Recently  in  September  of  2010,  an  outbreak  was  house outbreaks of CCHF [33].   
reported in Pakistan's Khyber Pakhtunkhwa province  Causative agent
[17]. So, India is always at potential risk of acquiring 
CCHFV is a member of Nairovirus genus of the  CCHFV from its neighbors. 
Bunyaviridae family [3]. It is enveloped spherical virus 
Table-1. Recent outbreaks of CCHF
approximately  100  nm  in  diameter  [4].  The  lipid 
Year Location/ Country References envelope is host derived, 5-7 nm thick, through which 
2008 Bulgaria [18] glycoprotein spikes, 8-10 nm in length protrude out 
2008 Sudan [13] [34, 35]. The genome, around 19.2 kb, consists of three  2008 Turkey [19]
2009 Iran [20] segments  of  negative  sense  single  stranded  RNA 
2009 Kazakhstan [21] segments designated as Large (L), Medium (M) and 
2009 Tajikistan [22]
Small  (S)  and  encode  for  viral  polymerase  (L),  2009 Afghanistan [23]
2010 Pakistan [17] Glycoprotein precursor (GPC) and Nucleocapsid (N) 
2011 India [24] respectively  [36].  A  schematic  representation  of 
CCHFV genome is given in the Figure-1. The latter two  Seasonal  variations  have  been  reported  in  the 
form  the  structural  proteins.  The  Glycoprotein  occurrence of CCHF. In Iran, higher number of cases 
precursor  undergoes  proteolytic  processing  to  form  reported in August and September [25]. In Pakistan 
structural proteins Gn (37kDa) and Gc (75kDa) and  high incidence is common between March and May, 
possible non structural proteins (mucin,GP160, GP85,  and  again  between  August  and  October,  showing 
GP38 and NSm). In case of Indian isolate L, M and S  biannual  surge  [26].  Climatic  change  is  always  a 
segments are 12166 bp, 5396 bp and 1667 bp long and  contributing factor for the occurrence of disease that 
encode proteins of 444.6 kDa, 186.9 kDa and 53.97  affects the reproduction of tick population resulting in  
kDa respectively [36].  increased incidence of tick born infections [27, 28].  
The first documented outbreak of CCHF in India 
was reported from Ahmedabad, Gujarat province of 
western India in December 2010 [24]. Four human 
deaths occurred among which the first victim a 32-year 
old  housewife  of  Korat  village  in  Sanand  died  on 
rd January 3 , 2011 [29]. The 35-year-old doctor treating 
th her died on 13  January, 2011 and an accompanying 
th nurse died on 18  January, 2011 [29]. The National 
Institute  of  Virology  (NIV),  Pune  confirmed  the 
positive testing of CCHFV, identified for the first time 
in  India  [29].  A  25-year-old  doctor  working  as  a 
medical intern became the next victim of CCHF virus 
and died on 31st January [29]. He was the second 
doctor and fourth victim overall to die of deadly disease 
in Ahmedabad. All deaths have occurred in less than a  Figure-1. Schematic  representation  of  CCHFV  genome.  (A).  S 
segment  encodes  for  nucleocapsid,  (B).  M  segment  encodes  month [29, 30]. The death pattern shows that all the 
glycoprotein precursor which undergo proteolytic cleavage to form  persons died of CCHF were living in close association 
structural proteins Gc and Gn and non-structural protein Nsm., (C). L 
of livestock or were the doctors treating the infected  segment encodes for viral polymerase. (self-designed figure)
cases.
Phylogenetic diversity in CCHFV
Transmission from tick or animal-to-human: Animals  Previous  studies  based  on  serological  testing 
do not show clinical signs but may act as a source of  suggested  very  few  significant  differences  among 
infection for humans [31]. The virus is transmitted  CCHFV strains [5]. However studies based on nucleic 
from animals to humans either by direct contact with  acid  sequencing  analysis  revealed  extensive  global 
blood or tissue of infected animal. The tick biting or  genetic diversity [37, 38]. The phylogenetic study of 
crushing of tick on skin or mucous membrane may be  various  CCHFV  S,  M  and  L  segment  sequences 
potential routes for transmission of CCHFV from tick  available  revealed  the  formation  of  distinct  groups 
to human [32].  [38]. The virus isolates circulating in our neighboring 
country Pakistan is having considerable variation in S  Human-to-human  transmission: Human- to- human 
segment sequence from the Indian isolates [36]. So the  transmission  occurs  by  direct  contact  of  virus 
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possibility  of  introduction  of  CCHFV  from  the  tissues results in longer incubation period. In Indian 
neighboring  country  cannot  be  ruled  out.  The  cases, the incubation  period ranged from 7-12 days 
phylogenetic study of Indian isolates performed by  through the later mode [4, 24, 29]. 
Yadav P. D. et al (2012) revealed that the S segment was  Pre-hemorrhagic symptoms are non specific and 
closest to a Tajikistan strain TADJ/ HU8966 of South- include  fever,  chills,  severe  headache,  dizziness, 
Asia 2 type while the M segment was found to be of  photophobia, myalgia and arthralagia. This phase may 
type M2 [36] . Both M and L segments were closest to  last for 1-7 days [44]. The hemorrhagic phase develops 
an Afghanistan strain Afg09-2990. Thus the Indian  suddenly lasting for 2-3 days [44]. A petechial rash may 
isolates were found as a South-Asia 2/M2 far-east virus  be  the  first  symptom  both  on  the  internal  mucosal 
combination  and  it  may  be  an  intra-genotypic  surfaces such as mouth and throat and on the skin. They 
reassortant [36].  are followed by ecchymoses and other hemorrhagic 
phenomenon such as hematemesis, melena, epistaxis,  Reservoir and vector
hematuria,  and  hemoptysis.  Hepatomegaly  and 
Like other tick born zoonotic agents, CCHFV  spleenomegaly can be seen in some patients [31, 45]. 
follows an enzootic tick-vertebrate-tick cycle [1, 4].    There may be rapid kidney deterioration. Death may 
There is no evidence of clinical disease in animals but a  occur in many cases. The mortality rate is 30% and the 
wide  range  of  domestic  and  wild  animals  act  as  case fatality rate is up to40%[40]. In Indian cases death 
reservoir for CCHFV [2, 31]. The CCHFV has been  occurred due to cardio respiratory arrest, multiorgan 
isolated  from  various  domestic  and  wild  animals  failure  and  disseminated  intravascular  coagulation 
including cattle, sheep, goats, hares, hedgehogs, mice  (DIC) and gastrointestinal bleeding in one case [29]. In 
(Mastomys  spp.)  and  domestic  dogs  [4,  32].  On  patients who survive recovery begins 10-20 days after 
serological testing the antibodies against CCHFV has  onset of illness. Recovery may take up to a year [24]. 
been found in various wild and domestic animals even  No clear pathogenesis is described for CCHF. 
in a Tortoise in Tajikistan [32]. Most of the birds are  Endothelial damage is a common feature leading to 
thought to be resistant to CCHF infection; however  capillary fragility and accounts for the characteristic 
some  reports  are  available  in  ostriches  where  rash  and  contributes  to  hemostatic  failure  by 
experimentally infection was produced [39, 40]. In  stimulating platelet aggregation and degranulation [4]. 
South  Africa,  cases  have  been  reported  where  the  Thrombocytopenia  occurs  and  dysregulation  of  the 
persons working in commercial ostrich slaughter house  coagulation cascade leads to DIC. Proinflammatory 
suffered from disease [41]. Birds may transfer the virus  cytokines are important in pathogenesis and the IL-
infected  ticks  even  though  they  themselves  remain  6and  TNF-α  level  are  significantly  higher  in  fatal 
non-viremic.In a study recently CCHF was detected in  CCHF [46].A study shows that viral genome can be 
the ticks from migratory birds in Morocco [42]. So the  detected from saliva and urine of infected patient [47]. 
migratory birds may be a reason of transport of virus  In CCHF there is increased serum ferritin level which 
from one place to other distinct places [42, 43]. Apart  can  be  used  as  a  marker  for  disease  activity  and 
from migratory birds, international trade and transport  prognosis [48].
of livestock carrying ticks may transport virus from 
Public health importance  one country to other [43].
Tick act as both reservoir as well as vector for  Humans readily succumb to CCHFV infection. 
CCHFV.  CCHFV  can  infect  a  number  of  ticks  of  However  domestic  animals  are  either  refractory  or 
Ixodidae  family  but  particularly  ticks  of  genus  undergo  mild  infection  with  transient  viremia 
Hyalomma are the most common and efficient vectors  sometimes, but they act as a main source of infection 
of  CCHFV  [32,  40].  Transovarial,  transtadial  and  for humans [49]. Persons living in close contact with 
venereal mode of transmission of virus is found in  animals  are  at  the  high  risk  of  getting  CCHF.   
vector [32]. So the tick remains infected throughout its  Veterinarians and farmers may castrate, dehorn, attach 
life and transfer virus from one generation to next  ear tags and immunize young animals and thus expose 
generation.  Immature ticks feed on the blood of small  themselves to the virus infected blood. They may have 
animals while the mature tick transfer infection to large  broken skin or scratch on the skin through which they 
may  get  infected.  Consumption  of  unboiled  or  animals including domestic livestock [1, 3]. 
uncooked meat and milk of infected animal may be a 
Clinical features and pathogenesis  potential  source  of  infection  [2].  There  is  lack  of 
CCHFV infections are asymptomatic in animals  evidence of disease in urban consumers of meat but the 
and birds are thought to be resistant. Humans are the  infected  animal  may  reach  to  abattoir  to  pose  a 
main victims to this disease. The course of the disease  potential  threat  for  workers  and  meat  consumers. 
can  be  divided  into  four  phases-  incubation,  pre- Exposure  to  aerosols  while  working  with  infected 
hemorrhagic, hemorrhagic and convalescence [3]. The  animals and in the hospital setting are the potential 
incubation period depends on the mode of infection.  hazards. The population in the infected or infection 
Infections  acquired  via  tick  bites  usually  become  prone area should be aware of the potential routes of 
apparent  after  1-3  days  [4].  Exposure  to  blood  or  infection and the safety measures to be taken to avoid Available at www.veterinaryworld.org/Vol.6/Oct-2013/24.pdf
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the  infection[40].  CCHFV  may  be  used  for  done  without  the  need  to  culture  the  virus  which 
bioterrorism or as a biowarfare agent [2]. Due to this it  requires BSL-4 facility [4]. Molecular epidemiology 
is included in CDC/NIAID Category C Pathogen [32].  can also be performed by this technique. A further 
improvement on the conventional RT-PCR assay has  Diagnosis 
been the advent of automated real-time PCR based 
To save the patient and to prevent the further  assays. The real-time PCR is more advantageousover 
transmission of disease, early diagnosis is essential.  conventional  RT-PCR  methods  with  respect  to 
The key indicators to suspect CCHF infection includes  sensitivity, specificity and time taken for detection. 
compatible  clinical  manifestations  like  fever  and  Real- time PCR also offers less contamination rate. 
bleeding, history of tick bite, travel to endemic area and  There are various detection chemistries available for 
contact with infected cases and tick infested animals.  the  real  time  PCR  like  SYBR  green,  TaqMan  and 
The disease should be differentiated from the other  molecular beacon etc. There are several real-time RT-
VHFs, malaria, dengue, yellow fever, Kyasanur forest  PCR assays reported till now for CCHFV detection. 
disease, rickettsiosis and leptospirosis [31, 50]. The  Some  important  assays  developed  for  CCHFV 
knowledge  of  ecology  and  endemicity  of  CCHFV  detection  are  SYBR  green,  TaqMan  and  TaqMan- 
should  be  kept  in  mind  to  proceed  with  further  Minor Groove Binding (MGB) probe based assays [54, 
diagnosis.  The  methods  of  diagnosis  include  virus  55, 56].
isolation,  immunological  assays  like  ELISA  and  Treatment
molecular  diagnostic  methods  like  reverse 
In case of CCHF, treatment is mainly supportive.  transcription- polymerase chain reaction (RT-PCR) [1, 
It includes careful management of fluid and electrolyte  32].
balance depending upon the severity of illness [1].  CCHFV can be isolated from the blood, plasma 
Currently  there  is  no  specific  antiviral  therapy  for  and tissue of infected patient for the diagnosis. Virus 
CCHF  approved  by  United  States  Food  and  Drug  isolation  should  be  performed  in  a  high  bio-
Administration (FDA) for human use [30].  Ribavarin,  containment laboratory [31]. A variety of cell lines 
a  guanosine  analogue  is  found  effective  against  including vero, BHK-21, LLC-MK2 and SW-13 can be 
CCHFV [57-59]. CCHFV is susceptible to ribavirin in  used for virus culture [51]. Cell culture can detect only 
vitro  [58].  According  to  some  reports  oral  and  high virus concentration and only useful during first 
intravenous ribavirin is effective for treating CCHFV  five days of disease. Generally the virus produces no or 
infections[18]. In India one case recovered by the oral  little  cytopathic  effects  so  it  can  be  identified  by 
administration of ribavirin and discharged after ten  immunofluorescence assay using specific monoclonal  days  [50].  Passive  immunotherapy  using  specific  antibodies  [4].  The  traditional  method  of  animal  immunoglobulin CCHF-Venin is also found beneficial  inoculation of newborn mice is more sensitive than cell  in CCHFV treatment [30]. culture and also detects the virus for longer period [52].  
Prevention and control The virus isolation by cell culture is of limited value 
because it needs a biosafety level-4 laboratory (BSL-4)  The  prevention  and  control  should  be  both  at 
which is unavailable in most of the endemic areas [31]. community  level  as  well  as  in  nosocomial  set  up.   
In the first few days of illness usually the patients do  Minimizing human contact with suspected livestock 
not develop a measurable antibody response so the  and reducing the tick burden in the animals are the 
serological tests are useful in the second week of illness  primary and most important preventive measures [40]. 
[1]. There are various serological tests available for  Animals  should  be  carefully  monitored  for  tick 
detection of CCHFV but these tests are of limited use in  infestation and treated by appropriate acaricidal agents 
fatal cases as patients generally die without developing  particularly before slaughter or export. Wearing fully 
antibodies.  The  conventional  serological  test  for  covered  clothes  and  use  of  tick  repellent  is 
CCHFV like Complement fixation, heamagglutination  recommended to prevent tick attachment on the body 
inhibition  and  immunodiffusion  suffered  lack  of  surface. The unpasteurized milk and uncooked meat 
sensitivity and reproducibility [3]. This problem was  should  not  be  taken.  Human-  to-  human  infection 
solved  by  IndirectImmunofluorescence  assay  (IFA)  mainly occurs in the nosocomial setup by the contact of 
and Enzyme-linked immunosorbent assay (ELISA) for  infected blood or tissue. So use of protective clothing, 
the detection of IgM and IgG antibodies. Both IgM and  gloves, goggles and face-masks reduces the chances of 
IgG can be detected up to 7-9 days of illness by indirect  exposure [59]. Safe burial practices with proper use of 
FIA  [4,  53].  ELISA  has  replaced  the  conventional  disinfectants should be followed. Veterinarians, research 
methods for antibody detection. IgM can be detected  workers,  slaughter  house  workers  and  medical 
up to 4 months and IgG persist for 5 years post - professionals should take utmost care to reduce the 
infection but its level decrease [4].  contact with suspected material. They should take the 
Molecular  diagnostic  assays  such  as  reverse  prophylactic  treatment  after  high  risk  exposure. 
transcriptase polymerase chain reaction now serve as  Laboratory and research workers are advised to follow 
the front-line tool in the diagnosis of CCHF [54]. PCR  stringent  biosafety  precautions  during  handling  the 
based methods are sensitive, specific, rapid and can be  pathogen and the work should be carried out under Available at www.veterinaryworld.org/Vol.6/Oct-2013/24.pdf
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EuroSurveill, 15(10):pii=19504. BSL-4 facilities. Virus can be inactivated by using 1% 
15. Vescio, F.M.,  Busani, L., Mughini-Gras, L., Khoury, C.,  hypochlorite and 2% glutaraldehyde [32]. Heating at 
Avellis, L., Taseva, E., Rezza, G. and Christova, I. (2012)  56°C for 30 minutes also destroy the virus [32]. Environmental correlates of Crimean-Congo haemorrhagic 
fever incidence in Bulgaria. BMC Public Health, 12:1116. Vaccination: Vaccine against CCHF is not available in 
16. Ozdarendeli,  A.,  Canakoglu,  N.,  Berber,  E.,  Aydin,  K.,  most of the countries. However a formalin inactivated  Tonbak, S., Ertek, M., Buzgan, T., Bolat, Y., Aktas, M. and 
vaccine derived from suckling mouse brain has been  Kalkan,  A.  (2010)The  complete  genome  analysis  of 
Crimean-Congo hemorrhagic fever virus isolated in Turkey.  used in Bulgaria and former Soviet Union [60]. There 
Virus Research, 147: 288–293. is no vaccine available for animal use [40]. 
17. ProMED-mail. Crimean-Congo hem. fever - Pakistan (09): 
(NW). ProMED-mail. (2010)  Oct. 15. 20090715.2529. Conclusion 
18. Christova, I., Di Caro, A., Papa, A., Castilletti, C., Andonova, 
CCHF  is  an  emerging  disease  in  India.  Its  L., Kalvatchev,, N.,Papadimitriou, E., Carletti, F., Mohareb, 
E., Capobianchi, M. R., Ippolito, G. and Rezza, G.( 2009)  zoonotic potential and fatality have created a great 
Crimean-Congo hemorrhagic fever, southwestern Bulgaria.  havoc in the general population as well as in health care 
Emerg Infect Dis, 15:983–985.  community. Since animals play an important role in the  19. Uyar, Y., Carhan, A., Albayrak, N. and Altaş, A.B. (2010) 
transmission of virus to human, the persons associated  Evaluation of PCR and ELISA-IgM results in the laboratory 
diagnosis of Crimean-Congo haemorrhagic fever cases in  with animals are at the great risk of CCHFV infection. 
2008 in Turkey. MikrobiyolBul, 44:57–64.  This disease is new to India so people should be aware 
20. Naderi, H.R., Sarvghad, M.R., Bojdy, A., Hadizadeh, M.R.,  of the various aspects of this fatal disease mainly its  Sadeghi, R. and Sheybani, F. (2010) Nosocomial outbreak 
modes of transmission, clinical manifestations, public  of Crimean-Congo haemorrhagic fever. Epidemiol Infect, 
27: 1–5. health importance and preventive measures.
21. ProMED-mail. Crimean-Congo hem. fever - Kazakhstan: 
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